Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tc 99m duramycin - Molecular Targeting Technologies

Next Previous
Search
Drug Profile

Tc 99m duramycin - Molecular Targeting Technologies

Alternative Names: 99mTc-Duramycin; Tc-99m-duramycin; TDURA; Technetium 99m duramycin; Technetium duramycin

Latest Information Update: 27 Feb 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Medical College of Wisconsin
  • Developer Molecular Targeting Technologies
  • Class Imaging agents; Peptides; Radioisotopes; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Colorectal cancer
  • Discontinued Cardiovascular disorders; Inflammation

Most Recent Events

  • 27 Feb 2024 No development reported - Phase-I for Colorectal cancer (Diagnosis, In volunteers) in Belgium (IV) (NCT05177640)
  • 14 Dec 2021 Molecular Targeting Technologies completes a phase I trial in Colorectal cancer (Diagnosis, In volunteers) in Belgium (IV) (NCT05177640)
  • 11 Jul 2021 Phase-II clinical trials in Colorectal cancer (Diagnosis) (IV) (Molecular Targeting Technologies pipeline, July 2021)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top